Allogeneic Stem Cell Transplantation Clinical Trials

39 clinical trials for Allogeneic Stem Cell Transplantation across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging — RECRUITING · PHASE3
• CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT — RECRUITING · PHASE2
• Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention — RECRUITING · PHASE2
• Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
• CIBMTR Research Database — RECRUITING
• Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries — RECRUITING
• Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation — WITHDRAWN · PHASE2
• Ruxolitinib + Allogeneic Stem Cell Transplantation in AML — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant — TERMINATED · PHASE1
• IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation — COMPLETED · PHASE1
• Implementing and Testing the Effectiveness of an Integrated Model of Care after Allogeneic SteM Cell TransplantatIon faciLitated by eHealth Technology (SMILe) — a RCT at the Medical Center–University of Freiburg — OTHER
• Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD — COMPLETED · NA
• Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant — NOT_YET_RECRUITING · PHASE1
• HHV-6-specific T-cell Reconstitution Among Children and Adolescents After Allogeneic Stem. — COMPLETED
• Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells — COMPLETED · NA
• CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute Leukemia — COMPLETED · PHASE2
• Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation — COMPLETED
• Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience — COMPLETED
• Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) — OTHER · PHASE3
• Bisantrene for Relapsed /Refractory AML — COMPLETED · PHASE2
• Physical Exercise Therapy vs Relaxation in Allogeneic Stem Cell Transplantation (PETRA) — COMPLETED · NA
• Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation — COMPLETED · NA
• Role of Interferon-λ and Vaccine Response — COMPLETED
• Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation — OTHER · NA
• Cognition in Allogeneic Stem Cell Transplanted Patients and Sports — OTHER · NA
• Bortezomib to Treat Significant Complication of HSCT — COMPLETED · PHASE2
• Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation — WITHDRAWN · PHASE1
• Caphosol® Versus State-of-the-art Mouthcare in Patients With Allogeneic Stem Cell Transplantation: a Randomized Controlled Study About the Efficacy of the Mouth Rinse Caphosol® — COMPLETED · NA
• Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant — TERMINATED · PHASE1
• Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. — COMPLETED · PHASE1
• Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation — TERMINATED · PHASE3
• CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease — TERMINATED · PHASE1
• Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation — COMPLETED · PHASE2
• Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH — OTHER
• Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation — OTHER · PHASE2
• Exercise During the Allogeneic Stem Cell Transplantation — OTHER · PHASE3
• Multimodal Intervention in Allogeneic Stem Cell Transplantation — COMPLETED · PHASE3
• Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT) — OTHER · PHASE2

Refine this search